IMMUNITYBIO, INC. (IBRX) Total assets 2016–2025
IMMUNITYBIO, INC. (IBRX) total assets at each fiscal year-end, per SEC filings.
$501.9MFY2025 · since FY2016: $317.5M → $501.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $501.9M | +31.1% |
| FY2024 | $382.9M | -24.1% |
| FY2023 | $504.5M | +39.2% |
| FY2022 | $362.4M | -22.7% |
| FY2021 | $468.9M | +111.8% |
| FY2020 | $221.4M | -17.9% |
| FY2019 | $269.8M | +48.3% |
| FY2018 | $181.9M | -27.3% |
| FY2017 | $250.4M | -21.1% |
| FY2016 | $317.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IBRX financial trends
IBRX RevenueIBRX Net incomeIBRX Net marginIBRX Gross profitIBRX Gross marginIBRX Operating incomeIBRX Operating marginIBRX Operating cash flowIBRX Free cash flowIBRX Capital expendituresIBRX Return on equityIBRX Stock buybacksIBRX Dividends paidIBRX Total liabilitiesIBRX Shareholders’ equityIBRX overview →